These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24112305)

  • 1. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections.
    Stevens V; Geiger K; Concannon C; Nelson RE; Brown J; Dumyati G
    Clin Microbiol Infect; 2014 May; 20(5):O318-24. PubMed ID: 24112305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attributable cost and length of stay for central line-associated bloodstream infections.
    Goudie A; Dynan L; Brady PW; Rettiganti M
    Pediatrics; 2014 Jun; 133(6):e1525-32. PubMed ID: 24799537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impacts and risk factors for non-central line-associated bloodstream infection in 5046 intensive care unit patients: an observational study based on electronic medical records.
    Zhu S; Kang Y; Wang W; Cai L; Sun X; Zong Z
    Crit Care; 2019 Feb; 23(1):52. PubMed ID: 30777109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Healthcare Institutional Costs of Pediatric Home Parenteral Nutrition Central Line Infections.
    Raphael BP; Hazekamp C; Samnaliev M; Ozonoff A
    J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):e77-e81. PubMed ID: 29912033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
    Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
    PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
    Yu KC; Jung M; Ai C
    Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.
    Wong SW; Gantner D; McGloughlin S; Leong T; Worth LJ; Klintworth G; Scheinkestel C; Pilcher D; Cheng AC; Udy AA
    Am J Infect Control; 2016 May; 44(5):587-92. PubMed ID: 26874406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the cost attributable to central venous catheter-related bloodstream infection and its influencing factors in a tertiary hospital in China.
    Cai Y; Zhu M; Sun W; Cao X; Wu H
    Health Qual Life Outcomes; 2018 Oct; 16(1):198. PubMed ID: 30305105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
    Rhee Y; Heung M; Chen B; Chenoweth CE
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections.
    Khong CJ; Baggs J; Kleinbaum D; Cochran R; Jernigan JA
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):886-92. PubMed ID: 25990620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis.
    Ziegler MJ; Pellegrini DC; Safdar N
    Infection; 2015 Feb; 43(1):29-36. PubMed ID: 25331552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic burden of bloodstream infections in critical care patients with central venous catheters.
    Brunelli SM; Turenne W; Sibbel S; Hunt A; Pfaffle A
    J Crit Care; 2016 Oct; 35():69-74. PubMed ID: 27481738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections.
    Kelly T; Ai C; Jung M; Yu K
    Infect Control Hosp Epidemiol; 2024 Jul; 45(7):864-871. PubMed ID: 38374686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and associated mortality of central line-associated bloodstream infections at an intensive care unit in northern India.
    Mishra SB; Misra R; Azim A; Baronia AK; Prasad KN; Dhole TN; Gurjar M; Singh RK; Poddar B
    Int J Qual Health Care; 2017 Feb; 29(1):63-67. PubMed ID: 27940521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.
    Lessa FC; Mu Y; Ray SM; Dumyati G; Bulens S; Gorwitz RJ; Fosheim G; DeVries AS; Schaffner W; Nadle J; Gershman K; Fridkin SK; ;
    Clin Infect Dis; 2012 Jul; 55(2):232-41. PubMed ID: 22523264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.